125 related articles for article (PubMed ID: 36540019)
1. The role of surveillance imaging for resected high-risk melanoma.
Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
[TBL] [Abstract][Full Text] [Related]
3. Yield of baseline imaging for distant metastases in high-risk primary melanoma.
Yan MK; Adler NR; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
J Surg Oncol; 2022 Jun; 125(8):1312-1317. PubMed ID: 35262187
[TBL] [Abstract][Full Text] [Related]
4. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
5.
Jaeger ZJ; Williams GA; Chen L; Mhlanga JC; Cornelius LA; Fields RC
J Surg Oncol; 2022 Mar; 125(3):525-534. PubMed ID: 34741547
[TBL] [Abstract][Full Text] [Related]
6. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.
Madu MF; Timmerman P; Wouters MWJM; van der Hiel B; van der Hage JA; van Akkooi ACJ
Melanoma Res; 2017 Jun; 27(3):251-257. PubMed ID: 28225434
[TBL] [Abstract][Full Text] [Related]
7. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
[TBL] [Abstract][Full Text] [Related]
8. Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence.
Ibrahim AM; Le May M; Bossé D; Marginean H; Song X; Nessim C; Ong M
Ann Surg Oncol; 2020 Oct; 27(10):3683-3691. PubMed ID: 32363515
[TBL] [Abstract][Full Text] [Related]
9. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
[TBL] [Abstract][Full Text] [Related]
10. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL
Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039
[TBL] [Abstract][Full Text] [Related]
11. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
[TBL] [Abstract][Full Text] [Related]
12. Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
Helvind NM; Weitemeyer MB; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
Ann Surg Oncol; 2023 Apr; 30(4):2377-2388. PubMed ID: 36752970
[TBL] [Abstract][Full Text] [Related]
13. Utility of PET/CT in patients with stage I-III melanoma.
Avilés Izquierdo JA; Molina López I; Sobrini Morillo P; Márquez Rodas I; Mercader Cidoncha E
Clin Transl Oncol; 2020 Aug; 22(8):1414-1417. PubMed ID: 31873917
[TBL] [Abstract][Full Text] [Related]
14. The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma.
Ravichandran S; Nath N; Jones DC; Li G; Suresh V; Brys AK; Hanks BA; Beasley GM; Salama AKS; Howard BA; Mosca PJ
Surg Oncol; 2020 Dec; 35():533-539. PubMed ID: 33161362
[TBL] [Abstract][Full Text] [Related]
15. Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
Bloemendal M; van Willigen WW; Bol KF; Boers-Sonderen MJ; Bonenkamp JJ; Werner JEM; Aarntzen EHJG; Koornstra RHT; de Groot JWB; de Vries IJM; van der Hoeven JJM; Gerritsen WR; de Wilt JHW
Ann Surg Oncol; 2019 Nov; 26(12):3945-3952. PubMed ID: 30830540
[TBL] [Abstract][Full Text] [Related]
16. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?
England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C
Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755
[TBL] [Abstract][Full Text] [Related]
17. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H
Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064
[TBL] [Abstract][Full Text] [Related]
18. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
19. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
Broman KK; Bettampadi D; Pérez-Morales J; Sun J; Kirichenko D; Carr MJ; Eroglu Z; Tarhini AA; Khushalani N; Schabath MB; Sarnaik A; Sondak VK; Zager JS
Ann Surg Oncol; 2021 Nov; 28(12):6978-6985. PubMed ID: 34363118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
